Pricing Log in Create free account

Pelthos Therapeutics Inc. (PTHS) vs Tevogen Inc. (TVGN)

Pelthos Therapeutics Inc. and Tevogen Inc. are both Biotechnology companies. Pelthos Therapeutics Inc. and Tevogen Inc. are of similar size ($36.2M and $35.6M). Tevogen Inc. has the higher net margin (0.00% vs −199.5%) and the higher return on invested capital (0.00% vs −82.3%). Across the 12 metrics below, Pelthos Therapeutics Inc. leads on 6 and Tevogen Inc. on 6.

Valuation

Metric PTHS TVGN Biotechnology median
P/E n/m n/m 10.60
P/S 0.78 n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.88 n/m 9.02
Earnings yield (276.23%) (115.91%) (32.88%)
Free cash flow yield (126.55%) (56.79%) (23.13%)

Profitability

Metric PTHS TVGN Biotechnology median
Gross margin 78.59% — 68.51%
Operating margin (133.42%) 0.00% 0.00%
Net margin (199.50%) 0.00% 0.00%
Free cash flow margin (98.37%) 0.00% 0.00%
Return on equity 2,161.07% 123.10% (51.96%)
Return on assets (125.04%) (492.20%) (46.06%)
Return on invested capital (82.34%) 0.00% 0.00%

Growth

Metric PTHS TVGN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (61.12%) (130.86%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric PTHS TVGN Biotechnology median
Debt to equity (46.58) (0.72) 0.00
Current ratio 1.98 0.33 4.97
Net debt to EBITDA (0.45) (0.15) 1.01

Dividend

Metric PTHS TVGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PTHS TVGN Biotechnology median
Market cap 35.61m 36.21m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack